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Abstract: Cancer related fatigue is a chronic disease that may persist up to 10 years after successful
cancer treatment and is one of the most prevalent problems in cancer survivors. Cancer related
fatigue is a complex symptom that is not yet explained completely and there are only a few remedies
with proven evidence. Patients do not necessarily follow a treatment plan with regular follow ups.
As a consequence, physicians lack of knowledge how their patients are coping with their fatigue in
daily life. To overcome this knowledge gap, we developed a smartphone-based monitoring system.
A developed Android app provides activity data from smartphone sensors and applies experience
based sampling to collect the patients’ subjective perceptions of their fatigue and interference of
fatigue with the patients’ daily life. To evaluate the monitoring system in an observational study,
we recruited seven patients suffering from cancer related fatigue and tracked them over two to
three weeks. We collected around 2700 h of activity data and over 500 completed questionnaires.
We analysed the average completion of answering the digital questionnaires and the wearing time of
the smartphone. A within-subject analysis of the perceived fatigue, its interference and measured
physical activity yielded in patient specific fatigue and activity patterns depending on the time of day.
Physical activity level correlated stronger with the interference of fatigue than with the fatigue itself
and the variance of the acceleration correlates stronger than absolute activity values. With this work,
we provide a monitoring system used for cancer related fatigue. We show with an observational
study that the monitoring system is accepted by our study cohort and that it provides additional
details about the perceived fatigue and physical activity to a weekly paper-based questionnaire.
Keywords: fatigue; cancer survivor; remote monitoring; activity tracking
1. Introduction
Some cancer survivors are confronted with additional hurdles even after having defeated their
cancer. One of the most prevalent problems is cancer related fatigue (CRF): almost all cancer patients
suffer from CRF during treatment [1] and about 25% of cancer survivors suffer from CRF after
successful treatment for up to 10 years [2]: the exhausting treatment and stressful situation of the
severe disease are finished, yet CRF patients still feel constantly exhausted on a physical, mental and
psychological level. Furthermore, usual behaviours like regenerative sleeping do not improve the
tiredness of CRF patients.
The etiology of CRF is complex and includes physiological causes related to cancer treatment and
medication as well as behavioural factors such as fear, depression or insomnia and reduced physical
activity [2].
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A moderate to severe CRF reduces physical and mental capabilities. This can lead to inability
to work, impairment of social life, daily activities and hobbies, and can also negatively impact
relationships. Overall, this negative interference with daily life reduces quality of life [3,4]. During
FATIGUE2 study [3], 376 patients were interviewed about the physical, emotional, behavioural
and economical impact of fatigue after being treated with chemotherapy. In addition, 90% of the
interviewed patients suffered from fatigue (n = 301) and reported that CRF prevents them from
leading a normal life. Curt concludes that CRF reduces the quality of life (QoL) more than other
symptoms [3].
Psychological interventions and psycho-stimulant drugs have been used as therapies, although
evidence of efficacy is still low for both categories of intervention. Drugs have negative side effects
and a risk of addiction, leading to increased research for alternative treatment methods. Studies have
discovered evidence for cognitive behavioural therapy, mindfulness-based meditation [5], physical
interventions including moderate physical exercise, walking or yoga [6]. However, more research is
required to reveal deeper knowledge and understanding of the underlying mechanisms of the disease.
More detailed and individualised recommendations are needed on when, how often, how much and
what type of exercise is most effective in the context of other diseases as well, such as depression [7].
After a systematic review of studies investigating CRF, Prue et al. concluded that studies should
have a longitudinal design including frequent assessments of the fatigue and a healthy control group [8].
Kelley et al. confirm Prue with their conclusion that “additional well-designed randomised controlled
trials and meta-analyses appear warranted” [9].
Monitoring systems and mobile health have been explored for patients with other diseases such as
patients with cardiovascular diseases [10,11], mental diseases [12–16], Parkinson [17] and for patients
in rehabilitation [18]. Activities could be related to pain level [19] and mental health [20]. Furthermore,
Huh presents an intestersting approach how to visualize big data on smartphones for personalized
health activities in order to investigate obesity in Korea [21].
Timmerman et al. could correlate the severity of CRF with physical daily activity using a device
worn on the hip to measure acceleration [22].
Besides monitoring, mobile Health smartphone apps serve as a tool to provide cancer
information [23] and have educational purposes such as support cancer prevention (e.g., reminders to
use sun screen), early detection of cancer (e.g., skin cancer [24]), diagnosis and treatment [25].
However, the usage of the smart-phone as sole sensor and questionnaire platform for application
in fatigue cancer survivors has not yet been investigated according to current literature review [26].
This work examined how activity monitoring and digital questionnaires provided by the
smartphone could be applied in longitudinal studies, realising a fatigue assessment with a frequency
of several times per day. The study goal was to gain information concerning the course of fatigue,
patients’ behaviour and physical activity. Analysis of patients’ self-reports and activity data evaluated
the patients’ retention and revealed insights about the course of the perceived fatigue and activity
patterns of six patients. With our monitoring system, we contribute to the research of cancer related
fatigue by providing a monitoring system that
• is inexpensive and integrated in daily life of patients, since it is based on smartphones,
• is accepted by patients suffering from cancer related fatigue,
• allows to collect subjective data in terms of patients’ self-reports and objective behavioral data,
• is designed for long-term usage.
2. Materials and Methods
This sections describe the designed activity monitoring system, the protocol of the performed
observational study and the performed data analysis.
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2.1. Monitoring System
We implemented a monitoring system as depicted in Figure 1. It consists of a smartphone
(Samsung Galaxy S5, Samsung, Seoul, South Korea), an Android activity tracking app and a web-server
that receives and stores the data. The system design was re-used from [27]. In contrast to the system
that is described in [27], we focused here on activity monitoring with the smart-phone only. Hence,
we did not include any additional wearables as in [27].
questionnaires
continuous wearing/
sensor logging
Wi-Fi 
transmission
Patient Server
Figure 1. Monitoring system comprising of a smartphone with the activity monitoring app installed
and a data receiving web-server.
Android App
We re-used the app design that was developed following a patient-centric approach [27].
Transparent to the user, the app is collecting data concerning physical activity as described in
Table 1. In addition, the smartphone reminds the patient to fill out digital questionnaires following the
experience based sampling method (ESM).
Table 1. Data collected by the smartphone.
Modality Description Sampling Rate
Questionnaires
two simple to use visual analogue scales allow to rate the
level of perceived fatigue and interference in a range from
0 (not tired/no interference)–10 (extremely tired/extreme
interference). The third question provides a selection of
7 daily activities, e.g., relaxing, housework, multimedia,
and a blank card (“Other”).
4 random times per day
(based on ESM)
Physical Activity The sampling rate of sensor measurements is controlledby Android and varies depending on usage.
Accelerometer 40 Hz
Barometer 2 Hz
Magnetometer 10 Hz
The questionnaires are collected via a patient interface that is integrated in the activity monitoring
app. Via vibration alarm, the smartphone app reminds patients to report their perceived fatigue,
the interference of fatigue and the currently performed activity. To answer the first two questions,
the app shows visual analogue scales (VAS), and the last question is answered by pressing the
appropriate button. Following the ESM, the timing of the questionnaires is randomised—ensuring
that the whole day is covered. Figure 2 shows the design of the two types of questionnaires. To allow a
simple selection of an activity, the app provides seven activities and a blank card “Other”.
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a) fatigue scale c) activity selection b) interference scale
Figure 2. Design (a) of the visual analogue scale to rate the perceived fatigue and (b) of the VAS to rate
the perceived interference of fatigue and (c) of the selection of the currently performed activity (English
translations from German original).
Each input has to be saved explicitly via a confirmation dialogue as shown in Figure 3.
Figure 3. Confirmation dialogue.
2.2. Data Transmission
Once per day, the activity monitoring app performs a task to upload the data using a wireless
connection. To ensure a reliable network connection, only WiFi networks are used and the upload
is performed preferably during night. Households without WiFi access are equipped with a mobile
hot-spot that is installed and tested during a visit at the patient’s home. In terms of robustness and the
Swiss mobile contract landscape, transferring data via WiFi networks is the optimal solution.
As the collected patient data are sensitive in terms of privacy and aimed studies need ethical
approval, the transmission of the collected data is secured via Secure Sockets Layer (SSL). In order to
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avoid traffic peaks at the web-server, the upload time is randomised. Data collection and transmission
were tested internally by members of our group.
Web-Server
The web-server is a implemented as a Tornado web server that listens for POST requests from the
smartphone app and stores received files in an upload directory.
2.3. Study Protocol
The study protocol with all necessary documents including informed consent, forms and
paper questionnaires for the patients, was approved by the local ethics committee (Kantonale
Ethikkommissision Zürich) as an amendment to the study with the number KEK-ZH-Nr. 2012-0563.
2.3.1. Patient Recruitment
Participants had to fulfil the following inclusion criteria:
• Aged > 18 years,
• mild to severe fatigue, i.e., FACIT-F ≤ 30 [28],
• willingness to use the provided smartphone,
• successful briefing how to use the smartphone and activity monitoring app,
• signed informed consent.
Excluded were patients with a relevant cognitive impairment or severe depression assessed by
M.I.N.I., a validated measure to assess psychiatric clinical disorders.
Patients were recruited by phone calls during which they were:
• explained the study concept and goal
• asked to participate in the study
• tested for eligibility, i.e., tested for fatigue FACIT-F and depression (M.I.N.I.)
2.3.2. Baseline
Interested patients were either visited at home or met at the university hospital or another
convenient place. They had to fill out and sign a general and informed consent. Participants were
provided with a smartphone (Samsung Galaxy S5) with the activity monitoring app pre-installed
and equipped with a prepaid SIM-card, the smartphone charger and a smartphone belt or pocket
depending on their needs. After introducing them to the app and, if necessary, to the smartphone, they
had to show that they were able to handle the device. If they had no WiFi at home, they received a
WiFi hotspot as well.
2.3.3. The Study Period
Naturally, the participants had the possibility to contact the study team at any time point.
At the third day after start, any upcoming questions concerning the devices or the study were
clarified during a home visit or phone call.
At four times per day (random in fixed time windows), the participants were notified via the
smartphone vibration alarm to answer the digital questionnaires. The frequency of four times per day
was chosen as trade-off between a comprehensive dataset using experience based sampling [29] and
a reasonable burden put on the group of fatigued patients that already have a reduced energy level
insufficient to perform the activities of daily life (ADL) [30].
The participants were asked to wear the smartphone the whole day long and charge it over night.
Weekly interviews comprised the FACIT-F questionnaire and the usage of the smartphone.
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2.3.4. The Study End
At the end of the follow-up interval, patients filled out again the FACIT-F and were interviewed
about their experiences during the study and using the smartphone and app in a personal meeting
using the technique of a guided conversation [31].
2.4. Data Analysis
The data were analysed in order to investigate the following research questions:
1. Is activity monitoring by the use of smartphones feasible in these patients that are often not
capable to achieve their daily tasks?
2. Can we generate patient-specific activity data with the goal to support research and interventions
for CRF?
2.4.1. Feasibility, Retention and Wearability
In addition to patients’ feedback collected during the final interviews, we evaluated the retention
of the patients with respect to smartphone and app usage by the following metrics:
• completeness of answering the digital self-reports,
• logging time of the smartphone,
• wearability index WI, denoting the percentage of time per day during which the phone was
on-body.
We excluded the first and the last day of study participation from data analysis, since those days
were incomplete per definition: at those days, the patients received or returned the smartphones,
respectively.
We defined the daily WI as the ratio between on-body samples and total samples
WI =
# on− body samples
# on− body samples + # o f f − body samples . (1)
A recorded test data set provided WI values for comparison. The phone was worn always
except for charging, sleeping, personal hygiene like taking a shower, etc. This yielded a value of
60% ≤ WI ≤ 70% over a day of 24 h. Since the smartphone shall not be switched off over night and
assuming 7 to 8 h of sleep during night, a WI of about 60% is close to the maximum possible for an
average person.
2.4.2. Smartphone On-/Off-Body Detection
To estimate the wearability index, we annotated the collected acceleration data with the labels
on-body and off-body. To distinguish between on-body and off-body based on the acceleration data,
we trained a classifier, based on the three-axis acceleration signals accx, accy, accz of the smartphone
acceleration sensor.
A recorded and labelled test data set consisting of four days was used to train and test the classifier
yielding in a F1 score of F1 = 0.81 for the class “off-body”.
The smartphone accelerometer delivers a signal with noise and varying sampling rate. Therefore,
we pre-processed and re-sampled the raw signals. We applied a sliding window (for parameters
ref. Table 2 on the Euclidean norm of the three acceleration signals (accx, accy, accz) to extract features
that were used as input for the classifier. Using the Euclidean norm instead of the three individual
axes allowed for train a classifier independently from the smartphone position. We trained a support
vector machine (SVM) with radial basis function (RBF) kernel. The optimal parameters C and gamma
were determined by grid search and are given in Table 2.
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Table 2. Parameters for applied sliding windows and for the trained SVM.
Parameter Name Value
windows size 256 samples
step width 1
C 31.62
gamma 0.0025
We processed the acceleration data per patient and day.
2.4.3. Descriptive Statistics and Exploratory Data Analysis
We report patients demographics and provide descriptive statistics on self-reports, weekly fatigue
assessments (FACIT-F) and activity measures. As an example, we visualise sedentary behaviour of a
patient using a heat map of the energy of the Euclidean norm (ref. Table 3) of the acceleration signal
over one minute windows.
For a patient-specific correlation analysis of VAS values with sensor data, we extracted the data
lying in the one hour time window preceding the VAS time stamp. On each time window, we extracted
features root mean square RMSxyz and variance VARxyz on the Euclidean norm of the three-axis x, y, z
and summarised the two features as indicated in Table 3 using the statistical measures variance, sum,
mean, 10 quantile and 90 quantile, maximum and minimum value. Since the energy (sum of RMS) of a
signal depends on the amount of on-body samples per time window, we considered also the energy
normalised by the wear-index.
Table 3. Statistical features extracted from the Euclidean norm of the three-axis acceleration signal:
these features are used for a fatigue-activity-correlation-analysis.
Feature Description
VARxyz.XX with XX ∈ {mean, variance, sum, minimum, maximum, lower10quantile, upper90quantile}
of VARxyz over 1 h window
RMSxyz.XX with XX ∈ {mean, variance, sum, minimum, maximum, lower10quantile, upper90quantile}
of RMSxyz over 1 h window
WEAR wearability index calculated over 1 h window
ENERGY RMSxyz.sum
ENERGY.WEAR RMSxyz.sum/weari f wear > 0, 0 otherwise
According to [32], we consider correlations with a Pearson’s correlation coefficient |r| ≥ 0.5 as
medium and values |r| ≥ 0.7 as strong.
3. Results
This section presents the results in three subsections. First, we give an overview over the recruited
patients. Second, we present the patients’ retention. Third, we present the results of the analysis of the
collected data.
3.1. Patients’ Demographics
We included seven patients (6 female (f), 1 male (m), median age = 52 years (32–73)). The patients
participated for two, respectively, three weeks. One female patient dropped out early due to health
reasons. We excluded the patient from our data analysis. Details on the patients are given in Table 4.
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Table 4. Overview on the included study participants. BL: baseline (**: value after week 1); *: drop out.
Pat. Id Age (Year) Gender FACIT-F (BL)
103 32 f 22 **
64 58 m 35
219 73 f 23
62 37 f 24
111 33 f 23
232 52 f 29
66 * 56 f 24
3.2. Feasibility and Retention
In total, we collected data on 124 days that yielded 2772 h of data and 523 answered questionnaires.
The final interviews covered the patients’ experiences with the smartphone app and the
smartphone itself. All patients stated that they could use intuitively the smartphone as well as
the app. Some patients missed activities to select, e.g., “work”. A possible solution for a future study
would be to allow a configuration of the selection of activities specific to the patients needs during the
initial meeting with the patient.
Except patient 219, all study participants were already smartphone users (Android smartphones
and iPhones). Naturally, some of them found it cumbersome to take care of a second phone. In the
future, this could be solved by also providing an activity app for iPhones and then installing the
activity monitoring app on the patients’ smartphone (Android or iPhone) instead of providing an
additional smartphone.
Table 5 shows that, on average, patients were handling the smartphone as advised: they kept the
smartphone switched on for most of the time (>22 h per day) and most of the patients answered the
questionnaires on average four times per day as requested. Patient 232 answered the questionnaire
also on her own initiative (which we allowed), in average 6.6 times per day.
Table 5. Daily averages of retention features: LT/d—avg logging time per day; d < 20 h—nb. of days
with less than 20 h logging time; q/d—avg nb. of answered questionnaires per day; WI—average
wearability index; WInorm—WI normalised to a 16 h day.
Pat. Id Participation (d) LT/d (h) d < 20 h q/d WI WInorm
103 32 23.6 1 4 25% 42%
64 16 22.0 2 3.3 33% 55%
219 31 23.9 0 3.9 43% 71%
62 15 23.1 1 4.1 42% 70%
111 15 21.6 3 4.1 38% 63%
232 15 23.0 1 6.6 48% 80%
Figure 4 shows that the answering rate remained constantly high during the whole study period:
Except for three days, all patients filled out the questionnaires at least once per day. At nine days,
the median number of answered questionnaires dropped below four answers; for the 22 other days,
the answering rate lies at or above the requested four answers.
Table 5 shows that, for all patients, it was more difficult to wear the smartphone all day long
than to fill out the questionnaires. WInorm specifies the WI when assuming an awake-time of 16 h
instead of calculating the WI w.r.t. a 24 h day. Despite repeating “to wear it at the body also at home”
during the briefing, patient 64 did not follow the instructions. The low WI of patients 103 and 111 is
explained by their statement that they were lying down large parts of the day. We expect better WI
when participants use their own smartphone. However, statements of the patients also indicate that
the WI itself is an indicator for physical activity: off-body periods denote home time and, depending
on the patient, sedentary time. Figure 5 illustrates that the average WInorm is stable over the whole
study period.
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Figure 4. Average answering rate of the six included patients. The bars denote the number of
participating patients, the violet line represents the number of patients that have answered at least once
the questionnaires and the green line denotes the median number of questionnaires that were answered
by these patients at a day. The dashed line denotes the requested number of four questionnaires
per day.
Figure 5. Average wearability index (normalised to a 16 h day) of the six included patients. The bars
denote the number of participating patients, the violet line represents the number of patients that have
worn the smartphone at a day and the green line denotes the average WI of these patients at a day.
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patient. For each reported pair, the dot size indicates the number of occurrences of this pair in the
dataset. Only for values 1 and 2, there is an accumulation of same answers. For the other values, the
diagonal is not overrepresented except for patient 64 who had either low fatigue and interference (2)
or high fatigue and interference (9) and only a few values in between. Hence, Figure 8 supports the
explanation no. 1, i.e., the more expressed the fatigue was, with the greater impact, it affected the
daily activities.
111 219 232
62 64 103
0 2 4 6 8 10 0 2 4 6 8 10 0 2 4 6 8 10
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Figure 8. Scatter plots of Fatigue vs. Interference of all digital questionnaires per patient: the dot size
represents the count of a VAS value pair. The diagonal denotes where Fatigue equals Interference.
Table 6 rises the question if all patients really distinguished between the two symptoms they were
asked for: patients 64 and 111 show nearly a correlation of 1.
Table 6. Individual Pearson’s correlations between perceived fatigue and perceived interference for
each patient.
Pat. Id Correlation Significance
103 r(97) = 0.62 p < 2.2 ×10−16
64 r(60) = 0.98 p < 2.2 ×10−16
219 r(59) = 0.57 p = 7.505 ×10−14
62 r(119) = 0.78 p = 5.87 ×10−12
111 r(51) = 0.95 p < 2.2 ×10−16
232 r(125) = 0.87 p = 1.211 ×10−14
From the observed relationship between perceived fatigue and interference, we propose the
following hypothesis that can be investigated in a future study:
1. The higher the fatigue, the more impact on daily activities. If one is less tired, it is probably
easier to ignore the lack of energy during activities of daily life. However, literature gives no
clear conclusions to confirm this hypothesis. Franke et al. have observed a similar behaviour in
fatigued patients suffering from Hepatitis C [33]. They found out that interference is a significant
predictor for depression. On the other hand, depressed patients were more likely to report a
severe fatigue.
2. The patients could not well distinguish between the two questionnaires. To investigate this
hypothesis, a future study can collect data from the digital questionnaires and correlate them with
validated instruments such as the Brief Fatigue Inventory that measures intensity and interference
of fatigue at the same time. Considering the result of [33], also depression should be controlled.
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3.4.3. Intra-Day Course of Fatigue
We used ESM for collecting the digital self-reports. The ESM unveiled that the fatigue is not
constant over the day. We grouped the self-reports’ values according to their timestamp in order to
identify patterns in the daily course. We adapted the habits of the German-speaking cultural area to
divide a day into time frames and defined six time windows of equal length:
late night 2–6 o’clock,
morning 6–10 o’clock,
midday 10–14 o’clock,
afternoon 14–18 o’clock,
evening 18–22 o’clock,
night 22–2 o’clock.
Naturally, there are only a few values available for night (seven reports over all patients) and late
night (one report). Figure 9 shows that the perceived fatigue varies during the day. In the cohort of this
study, there are different patterns present: in two patients, the fatigue increases during the day, one
patient has a decrease towards midday and followed by an increase towards the evening that is close
to the morning value, and three patients have a constant median all over the day, but with varying
inter-quartile range (IQR).
Figure 9. The box plot of perceived fatigue values per time at day shows intra-day variance. The sample
size is denoted in each box with n. The bold line in each box denotes the median, the box denotes
the IQR and the whiskers extend to the smallest value, highest value resp., within 1.5× IQR. Points
denote outliers, i.e., values that lie outside of the whiskers.
3.5. Analysis of Activity Data
3.5.1. Visualisation of Sedentary Behaviour
Figure 10 shows an example of the activity of one patient over her study period. A row represents
the activity of one day. The colour indicates the level of activity intensity: the lighter, the higher.
The activity is calculated as the energy of the signal over one-minute window and calculated as
the sum of the RMS (RMSxyz.sum) of the Euclidean norm of the acceleration signal recorded by the
smartphone. Patterns such as beginning and ending a day, periods of higher activity or sedentary
behaviour as well as wearing the phone are visualised and changes in the behaviour identified. In the
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example of Figure 10, almost each day, the patient takes the phone in the (late) morning and puts it
aside in the evening at differing times. This patient’s activity has small variance in the first two days.
Starting from day 3, there are some periods of higher activity denoted by the lighter colour and only
very few periods of high activity denoted by yellow colour. As expected, most of off-body data are
located at the beginning and end of the day and also include phases of resting.
Figure 10. Actigram of patient 232; rows present days; activity is aggregated as variance of the
acceleration signal over one-minute windows; grey represents off-body data, white shows gaps of data.
3.5.2. Correlation Analysis
We examined the correlations between activity features which are listed in Table 3 and
questionnaire values per patient. In total, we discovered 48 significant (p < 0.05) correlations: 26
features were correlated to fatigue in six patients and 22 features were correlated to interference in
five patients (no correlations in patient 232). Following an exploratory approach, we did not correct
the significant values for multiple testing. Table 7 lists the results for medium and strong correlations.
Table 7. Result of correlation analysis: the discovered correlations per patient are reported according
to the sign of the Pearson’s correlation coefficient r together with the number of patients npatients in
which these correlations were found.
Correlation Sign rFatigue(npatients) rInter f erence(npatients)
VAR pos 0.78–0.91 (2) 0.61(1)neg −0.8(1) −0.76(1)
RMS pos 0.6–0.76 (2) 0.61–0.63 (2)
WEAR pos 0.55(1) 0.61(1)
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All significant correlations occurred during the afternoon or evening and have a positive sign
except for one patient.
Variance-based features (VARxyz.XX as defined in Table 3) had medium to strong correlations
with both VAS values (fatigue and interference). In two patients (62, 111), these correlations were
positive and in one patient (232), this correlation was negative.
RMS-based features(RMSxyz.XX as it was defined in Table 3) had medium to strong positive
correlations for both VAS in two patients (62, 64). Since the features were calculated from a time
window that lies before the questionnaire answer, the positive correlation possibly indicates that
the patients felt more tired after a period of increased activity. The fact that the correlation with the
interference ratings was similar could mean that, due to the increased activity, the patients perceived
the fatigue as a bigger burden. However, we did not find literature examining these relationships on a
level of detail that allows conclusions on our hypotheses.
The feature WEAR (based on the wearability index) has a medium positive correlation in one
patient (64). Interestingly, this patient has a low average WI (ref. Table 5) because he stated that he did
not wear the smartphone at home. Therefore, we evaluate this correlation as a result by chance.
To summarise, the patient-specific correlation analysis did not discover specific correlations that
are consistent over the patient cohort. This is explainable by the fact that the participants differed in
the degree of their fatigue as well as that they were living in diverse circumstances concerning, e.g.,
their family status (single, mother of children, etc.) or work status (e.g., working, retired, incapable
of working). Nevertheless, consistently over the patient group, the correlations appeared during the
afternoon and evening, leading to the assumption that relationship between activity and fatigue is less
strong in the morning, after having rested during night.
The within-subject analysis unveiled a huge diversity in the patient group. This is reflected by the
correlation analysis and analysis of the questionnaires as well as by visualising the activity level as
illustrated in Figure 10.
4. Discussion
4.1. Summary of Results
This pilot study showed that adult patients suffering from a medium to severe CRF and not
having a depression or cognitive impairment are an eligible patient group for activity monitoring with
a smartphone. The patients achieved rates of around 90% of completeness for questionnaire answering
via the smartphone. However, wearing the phone on-body at home has been shown as being not
convenient or meaning too much effort for some patients.
The ESM based assessment of perceived fatigue unveiled information about the course of fatigue:
there is a variation of the perceived fatigue during the day. The participants of this study had three
different patterns of intra-day fatigue trends. The VAS scales showed the same trends as weekly
questionnaires.
We identified features extracted from the smartphone acceleration signal (VAR and RMS)
that correlate significantly with the VAS values during the afternoon and evening. Nevertheless,
the correlations are individual for each patient. This reflects the fact that self-reported, subjective
ratings of symptoms (such as the VAS used in this study) are naturally very specific to the individuals.
Gresham et al. identified 467 clinical trials in cancer populations involving wearable monitors that
measure physical activity (e.g., accelerometers, pedometers and multi-sensor systems) and analysed 46
of these studies and eight of these investigated cancer related fatigue. They stated that the median trial
size was 75 patients (IQR 36, 150) [34]. We conclude that our investigation concerning the relationship
between physical activity and perceived fatigue and interference of fatigue served to demonstrate
feasibility and created new hypothesis that are not yet investigated in literature, although they would
extend the knowledge in this field.
Information 2018, 9, 271 15 of 17
Gresham et al. conclude that these devices have a “relatively good prognosis” [34]. Our study is in
accordance with previous findings and shows that smartphones can compete with other devices with
respect to wearability. Furthermore, they provide the additional benefit of the possibility of experience
based sampling that allows for tracking the perceived fatigue in a higher frequency than a paper-based
questionnaire that is intended to be filled out weekly.
4.2. Advantages and Limits of Mobile Health
As an advantage, mobile health apps are cost effective and can provde access to medical care also
in rural areas or in developing countries. Smartphones give the opportunity to reach regions that are
not sufficiently covered with medical services [23,25].
In addition, our smartphone app is implemented in a modular way that allows for configuring the
amount of sensor logging and the frequency and content of self-reports. Therefore, it can be adapted
easily in order to monitor other patient groups, such as depressed patients or patients suffering from
multiple sclerosis. Giunti et al. reviewed the availability of smartphone apps for multiple sclerosis
patients and conclude that mobile health for this patient group has to be improved [35].
Furthermore, a continous monitoring can improve the treatment of patients, which is already
common in heart failure patients [10].
However, the quality of remote monitoring with smartphones relies on the compliance of the
participating patients. There is a risk of missing data and noise (e.g., when using GPS data while the
phone is indoor). Furthermore, mobile health has to include the care givers [25].
4.3. Limitations
The patient pool to recruit from was limited for this study. Hence, the sample size with six
evaluated patients is too small in order to draw general conclusions. The study period of 2–3 weeks
does not replace a longer study period in order to evaluate retention over a longer time frame.
4.4. Future Work
In future, other sensor modalities such as visited places and social behaviour could be investigated
as well to provide information about different aspects of the behavior CRF patients. The technology
can be used in future studies to study the behaviour of CRF patients. Smartphones could also be
used in intervention studies to measure activity related outcomes. The usage of smartphones has
the potential to simplify the study design, since no other devices need to be involved. Furthermore,
the app could be extended by an intervention, e.g., giving hints to improve sedentary habits.
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Abbreviations
The following abbreviations are used in this manuscript:
CRF cancer related fatigue
QoL quality of life
app smartphone application
VAS visual analogue scale
SSL secure sockets layer
FACIT-F functional assessment of chronic illness therapy-fatigue
M.I.N.I. mini international neuropsychiatric interview
ADL activities of daily life
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min minute
SVM support vector machine
RBF radial basis function
IQR inter quartile range
ESM experienced-based sampling method
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